Manning & Napier Group's NVO Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 182.2K shares of Novo Nordisk A/S (NVO) worth $10.11 M, representing 0.13% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Manning & Napier Group has initiated a new position in NVO, representing a fresh investment thesis on this company. Largest reduction occurred in Q3 2025, reducing 22.0K shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Manning & Napier Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +204,174 | New Buy | 204,174 | $69.02 |
| Q3 2025 | -21,973 | Reduce 10.76% | 182,201 | $55.50 |
Manning & Napier Group's Novo Nordisk A/S Investment FAQs
Manning & Napier Group first purchased Novo Nordisk A/S (NVO) in Q2 2025, acquiring 204,174 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Novo Nordisk A/S (NVO) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's largest addition to Novo Nordisk A/S (NVO) was in Q2 2025, adding 204,174 shares worth $14.09 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 182,201 shares of Novo Nordisk A/S (NVO), valued at approximately $10.11 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Novo Nordisk A/S (NVO) represents approximately 0.13% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's peak holding in Novo Nordisk A/S (NVO) was 204,174 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.